Want to see BMRA full AI Analyst Report?
Total Valuation
Biomerica has a market cap or net worth of $10.60M. The enterprise value is $8.41.
Market Cap$10.60M
Enterprise Value$8.41
Share Statistics
Biomerica has 4,588,968 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,588,968
Owned by Insiders11.03%
Owned by Institutions<0.01%
Financial Efficiency
Biomerica’s return on equity (ROE) is -1.44 and return on invested capital (ROIC) is -106.12%.
Return on Equity (ROE)-1.44
Return on Assets (ROA)-0.56
Return on Invested Capital (ROIC)-106.12%
Return on Capital Employed (ROCE)-1.24
Revenue Per Employee82.46K
Profits Per Employee-69.91K
Employee Count54
Asset Turnover0.66
Inventory Turnover2.40
Valuation Ratios
The current PE Ratio of Biomerica is ―. Biomerica’s PEG ratio is 0.05.
PE Ratio―
PS Ratio1.54
PB Ratio2.62
Price to Fair Value2.62
Price to FCF-2.01
Price to Operating Cash Flow-2.03
PEG Ratio0.05
Income Statement
In the last 12 months, Biomerica had revenue of 4.45M and earned -3.77M in profits. Earnings per share was -1.30.
Revenue4.45M
Gross Profit362.00K
Operating Income-5.32M
Pretax Income-3.75M
Net Income-3.77M
EBITDA-4.90M
Earnings Per Share (EPS)-1.30
Cash Flow
In the last 12 months, operating cash flow was -3.17M and capital expenditures 0.00, giving a free cash flow of -3.17M billion.
Operating Cash Flow-3.17M
Free Cash Flow-3.17M
Free Cash Flow per Share-0.69
Dividends & Yields
Biomerica pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.00
52-Week Price Change-20.62%
50-Day Moving Average1.71
200-Day Moving Average2.12
Relative Strength Index (RSI)76.75
Average Volume (3m)127.97K
Important Dates
Biomerica upcoming earnings date is Oct 9, 2026, TBA (Confirmed).
Last Earnings DateSep 1, 2026
Next Earnings DateOct 9, 2026
Ex-Dividend Date―
Financial Position
Biomerica as a current ratio of 1.62, with Debt / Equity ratio of 71.60%
Current Ratio1.62
Quick Ratio0.93
Debt to Market Cap0.07
Net Debt to EBITDA-0.12
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Biomerica has paid 23.00K in taxes.
Income Tax23.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Biomerica EV to EBITDA ratio is -1.52, with an EV/FCF ratio of -2.18.
EV to Sales1.67
EV to EBITDA-1.52
EV to Free Cash Flow-2.18
EV to Operating Cash Flow-2.18
Balance Sheet
Biomerica has $1.34M in cash and marketable securities with $193.00K in debt, giving a net cash position of $1.14M billion.
Cash & Marketable Securities$1.34M
Total Debt$193.00K
Net Cash$1.14M
Net Cash Per Share$0.25
Tangible Book Value Per Share$0.83
Margins
Gross margin is 4.32%, with operating margin of -119.47%, and net profit margin of -84.77%.
Gross Margin4.32%
Operating Margin-119.47%
Pretax Margin-84.26%
Net Profit Margin-84.77%
EBITDA Margin-110.02%
EBIT Margin-119.47%
Analyst Forecast
The average price target for Biomerica is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-16.17%
EPS Growth Forecast41.61%